Recordati Aktie - RER1

Recordati SpA (RER1) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

51,55

( 0,39% )

Gebot

51,50

Fragen

51,80

Volumen

152

51,55 Tagesbereich 51,55

0,00 52-Wochen-Bereich 0,00

Handelsende

51,35

Handelsbeginn

51,55

Letzte Trade

51.55

Letzter Handelszeitpunkt

09:26:30

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

IN TRIENNALE MILANO, RECORDATI CELEBRA I SUOI PRIMI 100 ANNI CON UNA MOSTRA CHE SVELA PER LA PRIMA VOLTA OGGETTI E IMMAGINI DEL SUO ARCHIVIO STORICO

IN TRIENNALE MILANO, RECORDATI CELEBRA I SUOI PRIMI 100 ANNI CON UNA MOSTRA CHE SVELA PER LA PRIMA VOLTA OGGETTI E IMMAGINI DEL SUO ARCHIVIO...

RECORDATI CELEBRATES ITS FIRST 100 YEARS AT TRIENNALE MILANO WITH AN EXHIBITION REVEALING OBJECTS AND IMAGES FROM ITS HISTORICAL ARCHIVE FOR THE FIRST TIME

RECORDATI CELEBRATES ITS FIRST 100 YEARS AT TRIENNALE MILANO WITH AN EXHIBITION REVEALING OBJECTS AND IMAGES FROM ITS HISTORICAL ARCHIVE FOR THE...

RECORDATI: IL FORTE SLANCIO DEL GRUPPO PROSEGUE NEL PRIMO TRIMESTRE DEL 2026 RICAVI NETTI +4,9%, EBITDA(1) +5,0%, UTILE NETTO RETTIFICATO(2) +7,2%

RECORDATI: IL FORTE SLANCIO DEL GRUPPO PROSEGUE NEL PRIMO TRIMESTRE DEL 2026 RICAVI NETTI +4,9%, EBITDA(1) +5,0%, UTILE NETTO RETTIFICATO(2) +7,2...

RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2%

RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2...

RECORDATI ANNUNCIA SOLIDI RISULTATI PRELIMINARI PER L’ESERCIZIO 2025: RICAVI +11,8%, EBITDA(1) +14,5%, UTILE NETTO RETTIFICATO(2) +14,5%;

RECORDATI ANNUNCIA SOLIDI RISULTATI PRELIMINARI PER L’ESERCIZIO 2025: RICAVI +11,8%, EBITDA(1) +14,5%, UTILE NETTO RETTIFICATO(2) +14,5%; Ricavi...

RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA(1) +14.5%, ADJUSTED NET INCOME(2) +14.5%

RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA(1) +14.5%, ADJUSTED NET INCOME(2) +14.5% Consolidated net...

RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA

RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA...

RECORDATI ANNUNCIA UNA COLLABORAZIONE STRATEGICA CON MODERNA PER SVILUPPARE E COMMERCIALIZZARE A LIVELLO GLOBALE mRNA-3927 PER IL TRATTAMENTO DELL’ACIDEMIA PROPIONICA

RECORDATI ANNUNCIA UNA COLLABORAZIONE STRATEGICA CON MODERNA PER SVILUPPARE E COMMERCIALIZZARE A LIVELLO GLOBALE mRNA-3927 PER IL TRATTAMENTO...

RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO GREATER THAN € 1.2 BILLION

RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO...

RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER

RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER NEWS RELEASE Milan, 23 October 2025 – Recordati, a global pharmaceutical company...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

RER1 - Frequently Asked Questions (FAQ)

What is the current Recordati SpA share price?

The current share price of Recordati SpA is 51,55 €

What is the 1 year trading range for Recordati SpA share price?

Recordati SpA has traded in the range of 0,00 € to 0,00 € during the past year

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Recordati SpA (RER1)

Recordati SpA (RER1) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

RER1 Neueste Nachrichten

IN TRIENNALE MILANO, RECORDATI CELEBRA I SUOI PRIMI 100 ANNI CON UNA MOSTRA CHE SVELA PER LA PRIMA VOLTA OGGETTI E IMMAGINI DEL SUO ARCHIVIO STORICO

RECORDATI CELEBRATES ITS FIRST 100 YEARS AT TRIENNALE MILANO WITH AN EXHIBITION REVEALING OBJECTS AND IMAGES FROM ITS HISTORICAL ARCHIVE FOR THE FIRST TIME

RECORDATI: IL FORTE SLANCIO DEL GRUPPO PROSEGUE NEL PRIMO TRIMESTRE DEL 2026 RICAVI NETTI +4,9%, EBITDA(1) +5,0%, UTILE NETTO RETTIFICATO(2) +7,2%

RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2%

RECORDATI ANNUNCIA SOLIDI RISULTATI PRELIMINARI PER L’ESERCIZIO 2025: RICAVI +11,8%, EBITDA(1) +14,5%, UTILE NETTO RETTIFICATO(2) +14,5%;

RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA(1) +14.5%, ADJUSTED NET INCOME(2) +14.5%

RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA

RECORDATI ANNUNCIA UNA COLLABORAZIONE STRATEGICA CON MODERNA PER SVILUPPARE E COMMERCIALIZZARE A LIVELLO GLOBALE mRNA-3927 PER IL TRATTAMENTO DELL’ACIDEMIA PROPIONICA

RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO GREATER THAN € 1.2 BILLION

RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER

RER1 - Frequently Asked Questions (FAQ)

RER1 Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Recordati SpA (RER1)

Recordati SpA (RER1) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

RER1 Neueste Nachrichten

IN TRIENNALE MILANO, RECORDATI CELEBRA I SUOI PRIMI 100 ANNI CON UNA MOSTRA CHE SVELA PER LA PRIMA VOLTA OGGETTI E IMMAGINI DEL SUO ARCHIVIO STORICO

RECORDATI CELEBRATES ITS FIRST 100 YEARS AT TRIENNALE MILANO WITH AN EXHIBITION REVEALING OBJECTS AND IMAGES FROM ITS HISTORICAL ARCHIVE FOR THE FIRST TIME

RECORDATI: IL FORTE SLANCIO DEL GRUPPO PROSEGUE NEL PRIMO TRIMESTRE DEL 2026 RICAVI NETTI +4,9%, EBITDA(1) +5,0%, UTILE NETTO RETTIFICATO(2) +7,2%

RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2%

RECORDATI ANNUNCIA SOLIDI RISULTATI PRELIMINARI PER L’ESERCIZIO 2025: RICAVI +11,8%, EBITDA(1) +14,5%, UTILE NETTO RETTIFICATO(2) +14,5%;

RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA(1) +14.5%, ADJUSTED NET INCOME(2) +14.5%

RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA

RECORDATI ANNUNCIA UNA COLLABORAZIONE STRATEGICA CON MODERNA PER SVILUPPARE E COMMERCIALIZZARE A LIVELLO GLOBALE mRNA-3927 PER IL TRATTAMENTO DELL’ACIDEMIA PROPIONICA

RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO GREATER THAN € 1.2 BILLION

RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER

RER1 - Frequently Asked Questions (FAQ)

RER1 Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich GRATIS und erhalten Sie:

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE